the cabinet
Drugs
6,918 products tracked
Marketed
retifanlimab
Zynyz (retifanlimab-dlwr)
Squamous Non-Small Cell Lung Cancer
Programmed cell death protein 1
$INCYINCYTE CORP
6 catalysts
pre_registrationdurvalumab
Imfinzi (durvalumab)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Programmed cell death 1 ligand 1
$AZNASTRAZENECA PLC
2 catalysts
unani medicine
Central Council for Research in Unani Medicine